To decide whether intravenous glutathione therapy is appropriate, a person's health history, lifestyle, and current health status should be considered
There are several different types of IV therapies available, each with its own unique benefits and uses
Phase 1b: Multiple Ascending Dose Study (NCT03014609) Study Title: "Safety, Tolerability, PK and PD of Multiple Doses of Cagrilintide in Subjects With Type 2 Diabetes" Status: Completed Phase: Phase 1b Enrollment: 56 participants with T2D Study Period: 2017-2018 Design: Randomized, double-blind, placebo-controlled Duration: 12 weeks Dose Range: 0.3-4.5 mg SC weekly Population: T2D, BMI 25-40, HbA1c 7-10% Key Results: Weight Loss: 6.0 kg (4.5 mg dose) vs
BPC-157 can be injected subcutaneously into the abdomen, upper outer thigh, or back of the upper arm for systemic effect